array:24 [
  "pii" => "S157821901930304X"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2018.06.029"
  "estado" => "S300"
  "fechaPublicacion" => "2019-12-01"
  "aid" => "2207"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2019"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "sco"
  "cita" => "Actas Dermosifiliogr. 2019;110:861-2"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 4
    "formatos" => array:2 [
      "HTML" => 2
      "PDF" => 2
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0001731019301668"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2018.06.019"
      "estado" => "S300"
      "fechaPublicacion" => "2019-12-01"
      "aid" => "2207"
      "copyright" => "AEDV"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "sco"
      "cita" => "Actas Dermosifiliogr. 2019;110:861-2"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 712
        "formatos" => array:2 [
          "HTML" => 523
          "PDF" => 189
        ]
      ]
      "es" => array:11 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Foro de Residentes</span>"
        "titulo" => "FR &#8211; Minoxidil oral para el tratamiento de la alopecia androg&#233;nica femenina y otras alopecias"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "861"
            "paginaFinal" => "862"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "RF &#8211; Oral Minoxidil for Female Pattern Hair Loss and Other Alopecias"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figura 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 708
                "Ancho" => 1255
                "Tamanyo" => 145540
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A&#41; Mujer de 33 a&#241;os con alopecia androg&#233;nica femenina antes del inicio del tratamiento con minoxidil oral 1<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46; B&#41; A los 12 meses de tratamiento&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "C&#46; Pindado-Ortega, D&#46; Saceda-Corralo, S&#46; Va&#241;&#243;-Galv&#225;n"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "C&#46;"
                "apellidos" => "Pindado-Ortega"
              ]
              1 => array:2 [
                "nombre" => "D&#46;"
                "apellidos" => "Saceda-Corralo"
              ]
              2 => array:2 [
                "nombre" => "S&#46;"
                "apellidos" => "Va&#241;&#243;-Galv&#225;n"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S157821901930304X"
          "doi" => "10.1016/j.adengl.2018.06.029"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901930304X?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019301668?idApp=UINPBA000044"
      "url" => "/00017310/0000011000000010/v1_201912070749/S0001731019301668/v1_201912070749/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1578219019303014"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2018.01.008"
    "estado" => "S300"
    "fechaPublicacion" => "2019-12-01"
    "aid" => "2105"
    "copyright" => "AEDV"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "sco"
    "cita" => "Actas Dermosifiliogr. 2019;110:e1-e2"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3
      "formatos" => array:2 [
        "HTML" => 1
        "PDF" => 2
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">e-Images in Dermatology</span>"
      "titulo" => "Squamous Cell Carcinoma on a Port Wine Stain"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "e1"
          "paginaFinal" => "e2"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Carcinoma epidermoide sobre mancha en vino de Oporto"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:6 [
          "identificador" => "fig0010"
          "etiqueta" => "Figure 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 689
              "Ancho" => 906
              "Tamanyo" => 67971
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "S&#46; Oscoz-Jaime, M&#46; Azcona-Rodr&#237;guez, J&#46;I&#46; Yanguas-Bayona"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "S&#46;"
              "apellidos" => "Oscoz-Jaime"
            ]
            1 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Azcona-Rodr&#237;guez"
            ]
            2 => array:2 [
              "nombre" => "J&#46;I&#46;"
              "apellidos" => "Yanguas-Bayona"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731018305027"
        "doi" => "10.1016/j.ad.2018.01.016"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018305027?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019303014?idApp=UINPBA000044"
    "url" => "/15782190/0000011000000010/v1_201912080808/S1578219019303014/v1_201912080808/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S157821901930294X"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2018.05.040"
    "estado" => "S300"
    "fechaPublicacion" => "2019-12-01"
    "aid" => "2234"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2019;110:859-60"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3
      "formatos" => array:2 [
        "HTML" => 1
        "PDF" => 2
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case for Diagnosis</span>"
      "titulo" => "A Nodule on the Breast after Radiation Therapy"
      "subtitulo" => "&#91;&#91;es&#93;&#93;N&#243;dulo en mama tras radioterapia"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "859"
          "paginaFinal" => "860"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1610
              "Ancho" => 750
              "Tamanyo" => 391312
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at0005"
              "detalle" => "Fig&#46; "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">B&#41;&#8239;Hematoxilina-eosina&#44; &#215;20&#46; C&#41;&#8239;Hematoxilina-eosina&#44; &#215;200&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "C&#46; Pindado-Ortega, D&#46; Ortega-Quijano, R&#46; Carrillo-Gij&#243;n"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "C&#46;"
              "apellidos" => "Pindado-Ortega"
            ]
            1 => array:2 [
              "nombre" => "D&#46;"
              "apellidos" => "Ortega-Quijano"
            ]
            2 => array:2 [
              "nombre" => "R&#46;"
              "apellidos" => "Carrillo-Gij&#243;n"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731019302182"
        "doi" => "10.1016/j.ad.2018.05.023"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019302182?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901930294X?idApp=UINPBA000044"
    "url" => "/15782190/0000011000000010/v1_201912080808/S157821901930294X/v1_201912080808/en/main.assets"
  ]
  "en" => array:15 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Resident&#39;s Forum</span>"
    "titulo" => "RF &#8211; Oral Minoxidil for Female Pattern Hair Loss and Other Alopecias"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "861"
        "paginaFinal" => "862"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "C&#46; Pindado-Ortega, D&#46; Saceda-Corralo, S&#46; Va&#241;&#243;-Galv&#225;n"
        "autores" => array:3 [
          0 => array:4 [
            "nombre" => "C&#46;"
            "apellidos" => "Pindado-Ortega"
            "email" => array:1 [
              0 => "cpindadoortega@gmail.com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "&#42;"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "D&#46;"
            "apellidos" => "Saceda-Corralo"
          ]
          2 => array:2 [
            "nombre" => "S&#46;"
            "apellidos" => "Va&#241;&#243;-Galv&#225;n"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital Ram&#243;n y Cajal&#44; Madrid&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "FR &#8211; Minoxidil oral para el tratamiento de la alopecia androg&#233;nica femenina y otras alopecias"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 708
            "Ancho" => 1253
            "Tamanyo" => 133975
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A&#44; Woman &#40;aged 33 years&#41; with female pattern hair loss before starting oral minoxidil treatment &#40;1&#160;mg&#47;d&#41;&#46; B&#44; Patient after 12 months of treatment&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Oral minoxidil &#40;2&#44;4-diamino-6-piperidinopyrimidine-3-oxide&#41; is a potent peripheral vasodilator that was initially used in the 1970s for the treatment of severe refractory hypertension at doses of 10&#160;mg&#47;day to 100&#160;mg&#47;day&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a> Owing to the development of hypertrichosis in a quarter of the patients who received this drug&#44; a topical formulation was developed to treat pattern hair loss&#44; first in men and subsequently in women&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The mechanism of action of minoxidil on the hair follicle is poorly understood&#46; Through the action of its active form&#44; minoxidil sulfate&#44; topical minoxidil shortens the telogen phase and causes resting follicles to prematurely enter the anagen phase&#46; It also prolongs the anagen phase and increases hair follicle size&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> Oral administration reduces blood pressure by inducing relaxation of vascular smooth muscle through the opening of sarcolemmal ATP2-dependent potassium channels&#46; Minoxidil&#39;s effect on the hair follicle is also thought to be mediated by minoxidil sulfate-induced opening of potassium channels&#44; although this remains to be demonstrated &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Due to the adverse effects observed at standard doses&#44; oral minoxidil is not widely used for the treatment of alopecia&#46; Evidence indicates that oral minoxidil at low doses &#40;0&#46;5&#8211;2&#46;5&#160;mg&#47;d&#41; is beneficial in the treatment of isolated cases of permanent alopecia caused by chemotherapy&#44;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> chronic telogen effluvium&#44;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> female pattern hair loss&#44;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> and monilethrix&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> In our experience&#44; oral minoxidil is a particularly interesting option for the treatment of female pattern hair loss and chronic telogen effluvium &#40;1&#160;mg&#47;d&#41; and male pattern hair loss &#40;5&#160;mg&#47;d&#41;&#46; It can be administered as monotherapy or in combination with a low-intensity topical minoxidil regimen &#40;e&#46;g&#46; 3 days per week&#41;&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">The main adverse effect is facial hypertrichosis&#44; the risk of which is dose-dependent &#40;4&#37; risk at 0&#46;25&#160;mg&#47;d&#44; 38&#37; risk at 1&#160;mg&#47;d&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">4&#44;5</span></a> This adverse effect is reversible upon discontinuation of treatment&#44; and in our experience is generally mild and does not pose a significant problem for the patient&#46; Isolated cases &#40;&#60;2&#37; of patients&#41; of postural hypotension and tachycardia have also been reported&#44;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> and therefore measurement of baseline blood pressure is recommended&#46; In patients with blood pressure values &#60;90&#47;60&#160;mmHg and those with postural hypotension &#160;sodium chloride &#40;50 mg&#41; should be added to the formulation&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> In our professional experience doses of 1&#160;mg&#47;day are safe and rarely cause hypotension&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">In Spain&#44; oral minoxidil is sold as 10-mg tablets for the treatment of severe arterial hypertension&#44; but it can be formulated in capsules&#46; In patients with female pattern hair loss the addition of spironolactone &#40;25&#160;mg&#41; reduces the risk of edema in the lower limbs and potentiates the therapeutic effects of minoxidil&#44; although theoretically spironolactone can worsen postural hypotension&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">In conclusion&#44; oral minoxidil at low doses is an interesting therapeutic alternative in patients who decline or do not tolerate topical administration&#44; especially in cases of female pattern hair loss&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:1 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1177565"
          "palabras" => array:3 [
            0 => "Minoxidil"
            1 => "Alopecia"
            2 => "Trichology"
          ]
        ]
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Pindado-Ortega C&#44; Saceda-Corralo D&#44; Va&#241;&#243;-Galv&#225;n S&#46; FR &#8211; Minoxidil oral para el tratamiento de la alopecia androg&#233;nica femenina y otras alopecias&#46; Actas Dermosifiliogr&#46; 2019&#59;110&#58;861&#8211;862&#46;</p>"
      ]
    ]
    "multimedia" => array:1 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 708
            "Ancho" => 1253
            "Tamanyo" => 133975
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A&#44; Woman &#40;aged 33 years&#41; with female pattern hair loss before starting oral minoxidil treatment &#40;1&#160;mg&#47;d&#41;&#46; B&#44; Patient after 12 months of treatment&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Minoxidil&#58; Mechanisms of action on hair growth"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "A&#46;G&#46; Messenger"
                            1 => "J&#46; Rundegren"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2133.2004.05785.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2004"
                        "volumen" => "150"
                        "paginaInicial" => "186"
                        "paginaFinal" => "194"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14996087"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "X&#46; Yang"
                            1 => "K&#46;-E&#46; Thai"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/ajd.12350"
                      "Revista" => array:6 [
                        "tituloSerie" => "Australas J Dermatol"
                        "fecha" => "2016"
                        "volumen" => "57"
                        "paginaInicial" => "e130"
                        "paginaFinal" => "e132"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25966934"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of chronic telogen effluvium with oral minoxidil&#58; A retrospective study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "E&#46; Perera"
                            1 => "R&#46; Sinclair"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.12688/f1000research.11775.1"
                      "Revista" => array:5 [
                        "tituloSerie" => "F1000Res"
                        "fecha" => "2017"
                        "volumen" => "6"
                        "paginaInicial" => "1650"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29167734"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Female pattern hair loss&#58; A pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "R&#46;D&#46; Sinclair"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/ijd.13838"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Dermatol"
                        "fecha" => "2018"
                        "volumen" => "57"
                        "paginaInicial" => "104"
                        "paginaFinal" => "109"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29231239"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of monilethrix with oral minoxidil"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "R&#46; Sinclair"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jdcr.2016.02.011"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAAD Case Rep"
                        "fecha" => "2016"
                        "volumen" => "2"
                        "paginaInicial" => "212"
                        "paginaFinal" => "215"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27284572"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000011000000010/v1_201912080808/S157821901930304X/v1_201912080808/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "34945"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Resident&#39;s Forum"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011000000010/v1_201912080808/S157821901930304X/v1_201912080808/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901930304X?idApp=UINPBA000044"
]
Share
Journal Information
Vol. 110. Issue 10.
Pages 861-862 (December 2019)
Vol. 110. Issue 10.
Pages 861-862 (December 2019)
Resident's Forum
Full text access
RF – Oral Minoxidil for Female Pattern Hair Loss and Other Alopecias
FR – Minoxidil oral para el tratamiento de la alopecia androgénica femenina y otras alopecias
Visits
35549
C. Pindado-Ortega
Corresponding author
cpindadoortega@gmail.com

Corresponding author.
, D. Saceda-Corralo, S. Vañó-Galván
Servicio de Dermatología, Hospital Ramón y Cajal, Madrid, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Full Text

Oral minoxidil (2,4-diamino-6-piperidinopyrimidine-3-oxide) is a potent peripheral vasodilator that was initially used in the 1970s for the treatment of severe refractory hypertension at doses of 10 mg/day to 100 mg/day.1 Owing to the development of hypertrichosis in a quarter of the patients who received this drug, a topical formulation was developed to treat pattern hair loss, first in men and subsequently in women.

The mechanism of action of minoxidil on the hair follicle is poorly understood. Through the action of its active form, minoxidil sulfate, topical minoxidil shortens the telogen phase and causes resting follicles to prematurely enter the anagen phase. It also prolongs the anagen phase and increases hair follicle size.2 Oral administration reduces blood pressure by inducing relaxation of vascular smooth muscle through the opening of sarcolemmal ATP2-dependent potassium channels. Minoxidil's effect on the hair follicle is also thought to be mediated by minoxidil sulfate-induced opening of potassium channels, although this remains to be demonstrated (Fig. 1).

Figure 1.

A, Woman (aged 33 years) with female pattern hair loss before starting oral minoxidil treatment (1 mg/d). B, Patient after 12 months of treatment.

(0.13MB).

Due to the adverse effects observed at standard doses, oral minoxidil is not widely used for the treatment of alopecia. Evidence indicates that oral minoxidil at low doses (0.5–2.5 mg/d) is beneficial in the treatment of isolated cases of permanent alopecia caused by chemotherapy,2 chronic telogen effluvium,3 female pattern hair loss,4 and monilethrix.5 In our experience, oral minoxidil is a particularly interesting option for the treatment of female pattern hair loss and chronic telogen effluvium (1 mg/d) and male pattern hair loss (5 mg/d). It can be administered as monotherapy or in combination with a low-intensity topical minoxidil regimen (e.g. 3 days per week).

The main adverse effect is facial hypertrichosis, the risk of which is dose-dependent (4% risk at 0.25 mg/d, 38% risk at 1 mg/d).4,5 This adverse effect is reversible upon discontinuation of treatment, and in our experience is generally mild and does not pose a significant problem for the patient. Isolated cases (<2% of patients) of postural hypotension and tachycardia have also been reported,4 and therefore measurement of baseline blood pressure is recommended. In patients with blood pressure values <90/60 mmHg and those with postural hypotension  sodium chloride (50 mg) should be added to the formulation.4 In our professional experience doses of 1 mg/day are safe and rarely cause hypotension.

In Spain, oral minoxidil is sold as 10-mg tablets for the treatment of severe arterial hypertension, but it can be formulated in capsules. In patients with female pattern hair loss the addition of spironolactone (25 mg) reduces the risk of edema in the lower limbs and potentiates the therapeutic effects of minoxidil, although theoretically spironolactone can worsen postural hypotension.4

In conclusion, oral minoxidil at low doses is an interesting therapeutic alternative in patients who decline or do not tolerate topical administration, especially in cases of female pattern hair loss.

References
[1]
A.G. Messenger, J. Rundegren.
Minoxidil: Mechanisms of action on hair growth.
Br J Dermatol, 150 (2004), pp. 186-194
[2]
X. Yang, K.-E. Thai.
Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil.
Australas J Dermatol, 57 (2016), pp. e130-e132
[3]
E. Perera, R. Sinclair.
Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study.
[4]
R.D. Sinclair.
Female pattern hair loss: A pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.
Int J Dermatol, 57 (2018), pp. 104-109
[5]
R. Sinclair.
Treatment of monilethrix with oral minoxidil.
JAAD Case Rep, 2 (2016), pp. 212-215

Please cite this article as: Pindado-Ortega C, Saceda-Corralo D, Vañó-Galván S. FR – Minoxidil oral para el tratamiento de la alopecia androgénica femenina y otras alopecias. Actas Dermosifiliogr. 2019;110:861–862.

Copyright © 2019. AEDV
Download PDF
Idiomas
Actas Dermo-Sifiliográficas
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?